Cardiogenic shock: A summary of the randomized SHOCK trial

Congestive Heart Failure

Volumn 9, Issue 1, 2003, Pages 35-39

  Menon, Venu ^a   Fincke, Rupert ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; CARDIOGENIC SHOCK; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL;

EID: 0037233668     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2003.tb00020.x     Document Type: Review

References (39)

1. Holmes DR, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol. 1995;26:668-674.
2. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial infarction. J Am Coll Cardiol. 1996;27:1321-1326.
3. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-1168.
4. Carnendran L, Abboud R, Gurunathan R, et al. Trends in cardiogenic shock: report from the SHOCK study. Eur Heart J. 2001;22(6):472-478.
5. Holmes DR, Califf RM, Van de Werf F, et al. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet. 1997;349:75-78.
6. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation. 1995;91:873-881.
7. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625-634.
8. Urban P, Stauffer J-C, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) Multicenter trial of Angioplasty for Shock - (S)MASH. Eur Heart J. 1999;20:1030-1038.
9. Hochman JS, Sleeper LA, Godfrey E, et al. Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J. 1999;137:313-321.
10. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36:1063-1070.
11. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36:1110-1116.
12. Sanders RJ, Kern WH, Blount SG. Perforation of the interventricular septum complicating myocardial infarction. Am Heart J. 1956;51:736-748.
13. Hutchins GM. Rupture of the interventricular septum complicating myocardial infarction. Am Heart J. 1979;97:165-173.
14. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993;329:1615-1622.
15. Batchelor WB, Peterson ED, Mark DB, et al. A comparison of US and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol. 1999;34:12-19.
16. Shawl FA, Domanski MJ, Hernandez TJ, et al. Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol 1989;64:967-970.
17. Franzosi MG, Santoro E, De Vita C, et al., on behalf of the GISSI Investigators. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation. 1998;98:2659-2665.
18. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTOIIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
19. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476-485.
20. Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction reperfusion. Circulation. 1998;97:1549-1556.
21. American Hospital Association. Hospital Statistics. Chicago, IL: American Hospital Association; 1992:208-209.
22. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34:890-911.
23. Hochman JS, Gersh BJ. Acute myocardial infarction: complications. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia, PA: Lippincott-Raven; 1998:437-480.
24. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
25. Zijlstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993; 328:680-684.
26. Webb J, Hochman J. Pathophysiology and management of cardiogenic shock due to primary pump failure. In: Gersh BJ, Rahimtoola SH, eds. Acute Myocardial Infarction. New York, NY: Chapman and Hall; 1997:308-337.
27. Neumann FJ, Walter H, Richardt G, et al. Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart. 1996;75:121-126
28. Webb JG, Carere RG, Hilton JD, et al. Usefulness of coronary stenting for cardiogenic shock. Am J Cardiol. 1997;79:81-84.
29. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol. 1998;31:294-300.
30. Schultz RD, Heuser RR, Hatler C, et al. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock. Cathet Cardiovasc Diagn. 1996;39:143-148.
31. Hasdai D, Holmes DR Jr, Topol EJ, et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase: results from GUSTO-III. Eur Heart J. 1999;20:128-135.
32. Prewitt RM, Gu S, Schick U, et al. Intra-aortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol. 1994;23:794-798.
33. Barron HV, Pirzada SR, Lomnitz DJ, et al. Use of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock. J Am Coll Cardiol. 1998;31(suppl A):135A
34. Ohman M, for the Thrombolysis and Counterpulsation to Improve Cardiogenic Shock Survival (TACTICS) investigators. Presented at the XXII Congress of the European Society of Cardiology; August 27, 2000; Amsterdam, The Netherlands.
35. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome, and prognostic factors. The MILIS Study Group. J Am Coll Cardiol. 1989;14:40-46.
36. Sprint Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission. Incidence of risk factors and outcome. Am J Med. 1993;94:265-273.
37. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation. 1995;91:1659-1668.
38. Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and tPA for Coronary Arteries Trial. Circulation. 2000;101:2231-2238.
39. Ryan TJ. Early revascularization in cardiogenic shock - a positive view of a negative trial. N Engl J Med. 1999;341:687-688.